BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: De Roza MA, Kai L, Kam JW, Chan YH, Kwek A, Ang TL, Hsiang JC. Proton pump inhibitor use increases mortality and hepatic decompensation in liver cirrhosis. World J Gastroenterol 2019; 25(33): 4933-4944 [PMID: 31543684 DOI: 10.3748/wjg.v25.i33.4933]
URL: https://www.wjgnet.com/1007-9327/full/v25/i33/4933.htm
Number Citing Articles
1
Luísa Martins Figueiredo, Maria Ana Rafael, Gonçalo Alexandrino, Joana C. Branco, Rita Carvalho, Mariana Nuno Costa, Alexandra Martins. Risk factors for the emergence of multidrug-resistant organisms in liver cirrhosisGastroenterología y Hepatología 2022; 45(3): 186 doi: 10.1016/j.gastrohep.2021.04.006
2
Hyun Jin Song, Xinyi Jiang, Linda Henry, Mindie H. Nguyen, Haesuk Park. Proton pump inhibitors and risk of liver cancer and mortality in patients with chronic liver disease: a systematic review and meta-analysisEuropean Journal of Clinical Pharmacology 2020; 76(6): 851 doi: 10.1007/s00228-020-02854-8
3
Xiaoli Wu, Daofu Zhang, Yuexiao Yu, Lianqing Lou, Xiaofei Li. Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studiesBioscience Reports 2020; 40(6) doi: 10.1042/BSR20193890
4
Hassan Ghoz, Payal Patel, Fernando Stancampiano, Sheetal Patel, Erin A. Fox, Mohammad B. Yousaf, Mohamed Omer, Michael G. Heckman, Matthew R. Spiegel, William C. Palmer. Proton-pump-inhibitor use associated with lower short-term rebleeding and mortality in patients receiving esophageal variceal band ligation: a retrospective cohort studyEuropean Journal of Gastroenterology & Hepatology 2020; 32(12): 1571 doi: 10.1097/MEG.0000000000001905
5
Shanshan Sun, Wenyi Ye, Ruihong Zhao, Jianhua Hu, Xuan Zhang, Meifang Yang, Hong Zhao, Jifang Sheng. Proton Pump Inhibitor Therapy Does Not Affect Prognosis of Cirrhosis Patients With Acute Decompensation and Acute-on-Chronic Liver Failure: A Single-Center Prospective StudyFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.763370
6
Luísa Martins Figueiredo, Maria Ana Rafael, Gonçalo Alexandrino, Joana C. Branco, Rita Carvalho, Mariana Nuno Costa, Alexandra Martins. Risk factors for the emergence of multidrug-resistant organisms in liver cirrhosisGastroenterología y Hepatología (English Edition) 2022; 45(3): 186 doi: 10.1016/j.gastre.2021.04.006
7
Liza Cholin, Tarek Ashour, Ali Mehdi, Jonathan J. Taliercio, Remy Daou, Susana Arrigain, Jesse D. Schold, George Thomas, Joseph Nally, Nazih L. Nakhoul, Georges N. Nakhoul. Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progressionBMC Nephrology 2021; 22(1) doi: 10.1186/s12882-021-02449-0
8
Keiji Yokoyama, Naoaki Tsuchiya, Ryo Yamauchi, Takashi Miyayama, Yotaro Uchida, Kumiko Shibata, Hiromi Fukuda, Kaoru Umeda, Kazuhide Takata, Takashi Tanaka, Shinjiro Inomata, Daisuke Morihara, Yasuaki Takeyama, Satoshi Shakado, Shotaro Sakisaka, Fumihito Hirai. Exploratory Research on the Relationship between Human Gut Microbiota and Portal HypertensionInternal Medicine 2020; 59(17): 2089 doi: 10.2169/internalmedicine.4628-20
9
Thomas H. Tranah, Victoria T. Kronsten, Debbie L. Shawcross. Implications and Management of Cirrhosis‐Associated Immune Dysfunction Before and After Liver TransplantationLiver Transplantation 2022; 28(4): 700 doi: 10.1002/lt.26353
10
Chia-Jung Kuo, Cheng-Yu Lin, Chun-Wei Chen, Chiu-Yi Hsu, Sen-Yung Hsieh, Cheng-Tang Chiu, Wey-Ran Lin. Risk of Enteric Infection in Patients with Gastric Acid Supressive Drugs: A Population-Based Case-Control StudyJournal of Personalized Medicine 2021; 11(11): 1063 doi: 10.3390/jpm11111063
11
Nadim Mahmud, Marina Serper, Tamar H. Taddei, David E. Kaplan. The Association Between Proton Pump Inhibitor Exposure and Key Liver-Related Outcomes in Patients With Cirrhosis: A Veterans Affairs Cohort StudyGastroenterology 2022;  doi: 10.1053/j.gastro.2022.03.052
12
Lukas Sturm, Laura Muller, Michael Schultheiss, Benedikt Binder, Jan Patrick Huber, Robert Thimme, Dominik Bettinger. Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinomaEuropean Journal of Gastroenterology & Hepatology 2021; 33(1S): e247 doi: 10.1097/MEG.0000000000002018
13
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortalityGastroenterología y Hepatología 2022; 45(1): 25 doi: 10.1016/j.gastrohep.2021.02.007
14
Alana Zulian Terres, Rafael Sartori Balbinot, Ana Laura Facco Muscope, Morgana Luisa Longen, Bruna Schena, Bruna Teston Cini, Gilberto Luis Rost, Juline Isabel Leichtweis Balensiefer, Louise Zanotto Eberhardt, Raul Angelo Balbinot, Silvana Sartori Balbinot, Jonathan Soldera. Evidence-based protocol for diagnosis and treatment of hepatorenal syndrome is independently associated with lower mortalityGastroenterología y Hepatología (English Edition) 2022; 45(1): 25 doi: 10.1016/j.gastre.2021.02.009
15
Ellen Stein, Josh Sloan, Irene Sonu, Priya Kathpalia, Daniela Jodorkovsky. GERD for the nongastroenterologist: successful evaluation, management, and lifestyle‐based symptom controlAnnals of the New York Academy of Sciences 2020; 1482(1): 106 doi: 10.1111/nyas.14496
16
Kelly L. Hayward, Rianne A. Weersink. Improving Medication‐Related Outcomes in Chronic Liver DiseaseHepatology Communications 2020; 4(11): 1562 doi: 10.1002/hep4.1612
17
Giulio Quarta, Cameron Zenger, David M. Feldman. Case–control study: Proton pump inhibitor use is a major risk factor for hepatic encephalopathy after TIPSGastroHep 2021; 3(3): 172 doi: 10.1002/ygh2.450
18
Yuan Bin Liu, Ming Kai Chen. The impact of proton pump inhibitors in liver diseases and the effects on the liverJournal of Digestive Diseases 2022; 23(4): 196 doi: 10.1111/1751-2980.13093
19
Igor G. Bakulin, Inna A. Oganezova, Maria I. Skalinskaya, Ekaterina V. Skazyvaeva. Liver cirrosis and complication risk managementTerapevticheskii arkhiv 2021; 93(8): 963 doi: 10.26442/00403660.2021.08.200917
20
Raquel de Oliveira Coberllini JACQUES, Lais da Silva MASSIGNAN, Martina Schumacher WINKLER, Rafael Sartori BALBINOT, Silvana Sartori BALBINOT, Jonathan SOLDERA. ACUTE-ON-CHRONIC LIVER FAILURE IS INDEPENDENTLY ASSOCIATED WITH LOWER SURVIVAL IN PATIENTS WITH SPONTANEOUS BACTERIAL PERITONITISArquivos de Gastroenterologia 2021; 58(3): 344 doi: 10.1590/s0004-2803.202100000-58
21
Meng Zhang, Xin Xu, Wei Liu, Zhongwei Zhang, Qiuyu Cheng, Zhongyuan Yang, Tingting Liu, Yunhui Liu, Qin Ning, Tao Chen, Junying Qi. Proton Pump Inhibitor Therapy Increases the Risk of Spontaneous Bacterial Peritonitis in Patients with HBV-Related Acute-on-Chronic Liver FailureAdvances in Therapy 2021; 38(9): 4675 doi: 10.1007/s12325-021-01844-1